Sen. Jack Reed

Maddy summaryThis bill, the Richard L. Trumka Protecting the Right to Organize Act of 2025, aims to strengthen workers' rights to organize and bargain collectively. It would make it harder for employers to classify workers as independent contractors by changing the definition of "employee," restricts employers from threatening to permanently replace workers who strike, and prohibits them from requiring employees to give up their right to pursue class or collective claims. The bill also changes election procedures to make it easier for workers to form unions, requires employers to post notices about workers' rights in conspicuous locations, and increases penalties for unfair labor practices. It directly affects employers and workers across various industries by altering the landscape of labor organizing and collective bargaining.

Maddy summaryThis bill repeals four executive orders issued on January 20, 2025, which related to energy policy and environmental agreements. It directly affects federal agencies responsible for implementing those orders, prohibiting the use of federal funds for any of their provisions. The key mechanism is an immediate ban on funding for the orders' implementation upon the bill's enactment, effectively canceling their legal force.

Maddy summaryThis bill closes tax loopholes by equalizing excise tax rates across all tobacco products. It increases cigarette taxes to $100.66 per pack, matches pipe tobacco tax to $49.56 per pound, sets smokeless tobacco at $26.84 per pound (with a new $100.66 tax per thousand single-use units), and imposes a new tax of $50.33 per 1,810 milligrams on nicotine for vaping products. The bill also establishes an annual inflation adjustment for tax rates starting in 2026 and requires manufacturers of nicotine to pay the tax unless products are FDA-approved for medical use. These changes primarily affect tobacco manufacturers and importers who will pay higher taxes on their products.

Maddy summaryS 803, the Keep Americans Safe Act, prohibits the import, sale, manufacture, transfer, or possession of large capacity ammunition feeding devices (devices holding more than 10 rounds, excluding specific .22 caliber tubular devices) in interstate or foreign commerce. It directly affects the general public, while exempting law enforcement officers (including campus police), retired officers with agency-issued devices, nuclear security personnel, and manufacturers testing under federal authorization. Key provisions include requiring serial numbers on new devices, expanding forfeiture for violations, and allowing federal Byrne grants to fund buy-back programs for surrendered devices. The bill takes effect upon enactment, with existing devices lawfully owned before enactment remaining legal.

Maddy summarySJRES 10, introduced by Senators Kaine and Heinrich, would terminate the national emergency related to energy declared by the President on January 20, 2025, under Executive Order 14156. This resolution ends the emergency as authorized by the National Emergencies Act, removing the special legal authorities granted during the emergency period. Upon passage, federal agencies would no longer operate under the emergency framework for energy-related policies, reverting to standard regulatory processes.

This resolution recognizes Black History Month as an opportunity to reflect on U.S. history and to commemorate the contributions of African Americans. It calls for the United States to (1) honor the contribution of pioneers who helped to ensure its legacy; and (2) move forward as a nation "indivisible, with liberty and justice for all."

Maddy summaryThis bill creates a streamlined process for out-of-state healthcare providers to enroll in Medicaid or CHIP (Children's Health Insurance Program) in a state. It directly affects children under 21 enrolled in these programs and healthcare providers located in other states who already meet low fraud risk standards. The key provision requires states to adopt a simplified enrollment process using only basic provider information (like name and National Provider Identifier), granting eligible providers a 5-year enrollment period without repeated screening. This reduces administrative barriers for providers serving out-of-state children under 21 who qualify for Medicaid or CHIP coverage.

Maddy summaryThis resolution (SRES 93) expresses the Senate's view that the National Institutes of Health (NIH) should not face funding disruptions or operational delays that violate existing law. It specifically highlights the importance of uninterrupted NIH work on research for diseases like cancer, Alzheimer’s, diabetes, and heart disease. The resolution emphasizes that NIH scientists and researchers are essential to medical progress and public health efforts. As a symbolic resolution, it does not change funding laws or create new policies - it solely states the Senate’s position on protecting NIH operations.

Maddy summarySRES 96 is a symbolic Senate resolution designating February 24-28, 2025, as "Public Schools Week" to honor public education. It does not create new laws, allocate funding, or directly affect any specific group - it is a non-binding recognition of public schools' role in U.S. communities. The resolution includes supportive statements about public education's importance but contains no policy mechanisms or requirements. This designation is intended to raise awareness and appreciation for public schools nationwide. As a procedural resolution, it has no legal effect beyond the symbolic recognition.

Maddy summaryThis bill modifies requirements for pediatric drug studies, particularly for drugs treating rare diseases (orphan drugs). It requires the FDA to issue a noncompliance letter and allow 45 days for response before imposing penalties, and creates an automatic FDA waiver list for diseases where pediatric studies are impractical. Drug sponsors developing orphan drugs for rare conditions will benefit from clearer pathways, as the bill specifies when pediatric studies aren't required unless they offer meaningful therapeutic benefit. The FDA must also report on penalties for noncompliance and update its waiver lists, aiming to streamline development while improving pediatric data for rare diseases.